Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to innovative therapies for ...

Quantum BioPharma (QNTM) announced the purchase of 2,000 shares of GameStop (GME) to hold on the Company’s balance sheet as a strategic ...

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, ... In 2021, when multiple brokerages removed the buy button on GameStop, ...

Quantum BioPharma shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial public offering.

Quantum BioPharma is considered a low-float stock with just 1.83 million shares available for public trading, according to Benzinga Pro. The company also had a market cap of approximately $6 ...

Quantum BioPharma Ltd., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has renewed the services of King Tide Media LLC ...

Investing.com -- Shares of Quantum (NASDAQ:QMCO) BioPharma Ltd. (NASDAQ: QNTM) surged 95% following the announcement of positive results from its clinical trial for the dietary supplement unbuzzd™.